HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of atrial fibrillation with outcomes in patients hospitalized with inflammatory bowel disease: an analysis of the National Inpatient Sample.

AbstractINTRODUCTION:
We aimed to determine in-hospital outcomes, length of hospital stay (LOS) and resource utilization in a contemporary cohort of patients with inflammatory bowel disease (IBD) and atrial fibrillation (AFIB).
MATERIAL AND METHODS:
The National Inpatient Sample database October 2015 to December 2017 was utilized for data analysis using the International Classification of Diseases, Tenth Revision codes to identify the patients with the principal diagnosis of IBD.
RESULTS:
Of 714,863 IBD patients, 64,599 had a diagnosis of both IBD and AFIB. We found that IBD patients with AFIB had a greater incidence of in-hospital mortality (OR = 1.3; 95% CI: 1.1-1.4), sepsis (OR = 1.2; 95% CI: 1.1-1.3), mechanical ventilation (OR = 1.2; 95% CI: 1.1-1.5), shock requiring vasopressor (OR = 1.4; 95% CI: 1.1-1.9), lower gastrointestinal bleeding (LGIB) (OR = 1.09, 95% CI: 1.04-1.1), and hemorrhage requiring blood transfusion (OR = 1.2, 95% CI: 1.17-1.37). Mean LOS ± SD, mean total charges and total costs were higher in patients with IBD and AFIB.
CONCLUSIONS:
In this study, IBD with AFIB was associated with increased in-hospital mortality and morbidity, mean LOS and resource utilization.
AuthorsEbad Ur Rahman, Vijay Gayam, Pavani Garlapati, Neelkumar Patel, Fatima Farah, Adee El-Hamdani, Arfaat Khan, Paul I Okhumale, Wilbert S Aronow, Mehiar El-Hamdani
JournalArchives of medical sciences. Atherosclerotic diseases (Arch Med Sci Atheroscler Dis) Vol. 6 Pg. e40-e47 ( 2021) ISSN: 2451-0629 [Print] Poland
PMID34027213 (Publication Type: Journal Article)
CopyrightCopyright: © 2021 Termedia & Banach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: